Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al.
Cancer Biotherapy and Radiopharmaceuticals · 2024
DOI: 10.1089/cbr.2023.0167 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Belma Gözde Özdemir. Beteiligte Einrichtung: Selcuk University, Faculty of Medicine, Department of Obstetrics and Gynecology, Konya, Turkey. Hauptthemen laut MEDLINE: Ovarian Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Selcuk University, Faculty of Medicine, Department of Obstetrics and Gynecology, Konya, Turkey.
ORCID-Profile: Belma Gözde Özdemir
Zitieren
APA
Özdemir, B. G. (2024). Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0167
Vancouver
Özdemir BG. Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0167
BibTeX
@article{zdemir2024,
author = {Özdemir, Belma Gözde},
title = {Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2024},
doi = {10.1089/cbr.2023.0167}
}
EUVIMED